Cargando…
Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics
Pulmonary hypertension is a debilitating condition that frequently develops in the setting of interstitial lung disease, likely related to chronic alveolar hypoxemia and pulmonary vascular remodeling. This disease process is likely to be identified more frequently by providers given recent advanceme...
Autores principales: | Haynes, Zachary A., Chandel, Abhimanyu, King, Christopher S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572438/ https://www.ncbi.nlm.nih.gov/pubmed/37830608 http://dx.doi.org/10.3390/cells12192394 |
Ejemplares similares
-
Pulmonary Hypertension in Interstitial Lung Disease: Management Options to Move Beyond Supportive Care
por: Fabyan, Kimberly D., et al.
Publicado: (2023) -
Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
por: Shumar, John N., et al.
Publicado: (2021) -
Depression in Pulmonary Arterial Hypertension and Interstitial Lung Diseases
por: Verma, Sameer, et al.
Publicado: (2014) -
Recent advances in the management of pulmonary hypertension with interstitial lung disease
por: Waxman, Aaron B., et al.
Publicado: (2022) -
Prevalence of pulmonary hypertension in patients with COVID‐19 related lung disease listed for lung transplantation: A UNOS registry analysis
por: Thomas, Christopher, et al.
Publicado: (2023)